{"issuance_frequency":"","notes_translated":{"fr":"Dans le cadre de la réponse générale du gouvernement à la pandémie, Santé Canada a mis en place des mesures réglementaires novatrices et agiles. Ces mesures permettent d'accélérer l'examen réglementaire des produits de santé liés à la COVID-19 sans en compromettre l'innocuité, l'efficacité et les normes de qualité.","en":"As part of the government's broad response to the pandemic, Health Canada introduced innovative and agile regulatory measures. These measures expedite the regulatory review of COVID-19 health products without compromising safety, efficacy and quality standards."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"e9793df9-895c-4c6f-969f-c04cc59cf960","metadata_created":"2021-04-28T16:41:13.127449","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-04-28T16:41:13.127455","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-04-28","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Réponse à la pandémie","réponse réglementaire au COVID-19","mesures réglementaires","accès aux produits de santé","mesures accélèrent l'examen réglementaire","normes de sécurité","d'efficacité et de qualité"],"en":["Response to pandemic","Regulatory response to COVID-19","regulatory measures","access to health products","measures expedite the regulatory review","safety","efficacy and quality standards"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Réponse de Santé Canada en matière de réglementation face à la COVID 19 : Accès aux produits de santé ","en":"Health Canada’s regulatory response to COVID-19: Access to health products "},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"e9793df9-895c-4c6f-969f-c04cc59cf960","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"14cc3230-7be7-484e-9daf-c0be92f773e5","related_relationship":"","name_translated":{"fr":"Réponse de Santé Canada en matière de réglementation face à la COVID 19 : Accès aux produits de santé ","en":"Health Canada’s regulatory response to COVID-19: Access to health products "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Health Canada’s regulatory response to COVID-19: Access to health products ","language":["en"],"created":"2021-04-28T16:41:13.269442","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/regulatory-response-health-product-access.html","last_modified":null,"position":0,"revision_id":"ade3256f-8898-46af-ad32-0800c9cfb3be","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"e9793df9-895c-4c6f-969f-c04cc59cf960","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9c5104c9-0853-4889-abef-6822864106f9","related_relationship":"","name_translated":{"fr":"Réponse de Santé Canada en matière de réglementation face à la COVID 19 : Accès aux produits de santé ","en":"Health Canada’s regulatory response to COVID-19: Access to health products "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Health Canada’s regulatory response to COVID-19: Access to health products ","language":["fr"],"created":"2021-04-28T16:41:13.269449","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/reponse-reglementation-acces-produits-sante.html","last_modified":null,"position":1,"revision_id":"ade3256f-8898-46af-ad32-0800c9cfb3be","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-03-31 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"e9793df9-895c-4c6f-969f-c04cc59cf960","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"As part of the government's broad response to the pandemic, Health Canada introduced innovative and agile regulatory measures. These measures expedite the regulatory review of COVID-19 health products without compromising safety, efficacy and quality standards.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Health Canada’s regulatory response to COVID-19: Access to health products ","revision_id":"ade3256f-8898-46af-ad32-0800c9cfb3be"}